Product Name : Ribociclib Succinate
CAS : 1374639-75-4.
Molecular Formula : C27H36N8O5
Molecular Weight : 552.6
Pharmaceutical Grade : IH
Therapeutic Category : Antineoplastic
Global calcium is one of the leading manufacturers and exporters of Ribociclib CAS No.1374639-75-4., API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, global calcium has stood the test of time since its inception in 1979.
As manufacturer of Ribociclib we hereby state the following facts about the drug:
Ribociclib is indicated for the:
treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:
an aromatase inhibitor as initial endocrine-based therapy; or
fulvestrant as initial endocrine-based therapy or following disease progression on endocrine therapy in postmenopausal women or in men.cer.
Mechanism of action
Ribociclib is a targeted cancer therapy that inhibits CDK4 and CDK6 to slow or stop the growth of hormone receptor-positive, HER2-negative breast cancer cells.
Global calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market.
